Chemomab Therapeutics Ltd. (CMMB)
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
CMMB Insider Trading Activity
CMMB Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Related Transactions
About Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and changed its name to Chemomab Therapeutics Ltd. in March 2021. Chemomab Therapeutics Ltd. was …
Insider Activity of Chemomab Therapeutics Ltd.
Over the last 12 months, insiders at Chemomab Therapeutics Ltd. have bought $0 and sold $0 worth of Chemomab Therapeutics Ltd. stock.
On average, over the past 5 years, insiders at Chemomab Therapeutics Ltd. have bought $2.07M and sold $2.5M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 33 shares for transaction amount of $91 was made by Maryles Joel Michael () on 2022‑05‑24.
List of Insider Buy and Sell Transactions, Chemomab Therapeutics Ltd.
| 2023-01-03 | Sale | OrbiMed Israel GP Ltd. | director | 336,900 3.61% | $3.58 | $1.21M | -53.74% | |
| 2023-01-03 | Sale | Mor George Adi | Chief Scientific Officer | 13,800 0.2073% | $5.03 | $69,370 | -53.74% | |
| 2022-11-16 | Sale | Mor George Adi | Chief Scientific Officer | 582,023 4.6768% | $2.08 | $1.21M | -32.46% | |
| 2022-11-16 | Sale | Cohen Neil Harris | director | 2,409 0.0186% | $2.00 | $4,818 | -32.46% | |
| 2022-05-24 | Maryles Joel Michael | 33 0.0003% | $2.76 | $91 | -20.36% | |||
| 2022-05-18 | Cohen Neil Harris | 2,000 0.0183% | $3.19 | $6,380 | -26.14% | |||
| 2022-03-18 | Maryles Joel Michael | 500 0.0043% | $4.36 | $2,180 | -37.28% | |||
| 2022-03-16 | Marvin Donald | Executive VP, CFO & COO | 250 0.0017% | $3.30 | $825 | -32.22% | ||
| 2022-03-14 | Cohen Neil Harris | 2,000 0.0186% | $4.20 | $8,400 | -27.20% | |||
| 2022-03-14 | Pfost Dale R | Chief Executive Officer | 1,800 0.0158% | $3.98 | $7,164 | -27.20% | ||
| 2022-03-14 | Marvin Donald | Executive VP, CFO & COO | 250 0.0022% | $4.00 | $1,000 | -27.20% | ||
| 2022-03-11 | Darvish Nissim | 1,200 0.0107% | $4.28 | $5,136 | -30.48% | |||
| 2021-12-06 | Cohen Neil Harris | director | 2,000 0.0175% | $7.43 | $14,860 | -54.24% | ||
| 2021-03-16 | THIEL PETER | 10 percent owner | 230,536 0.6772% | $17.35 | $4M | -83.55% | ||
| 2021-03-16 | Cohen Neil Harris | director | 2,409 0.0169% | $41.51 | $99,998 | -83.55% |
Insider Historical Profitability
| THIEL PETER | 10 percent owner | 1108509 117.5725% | $1.56M | 1 | 0 | <0.0001% |
| Cohen Neil Harris | director | 10000 1.0606% | $14,100.00 | 4 | 1 | <0.0001% |
| Pfost Dale R | Chief Executive Officer | 1800 0.1909% | $2,538.00 | 1 | 0 | <0.0001% |
| Marvin Donald | Executive VP, CFO & COO | 1750 0.1856% | $2,467.50 | 2 | 0 | <0.0001% |
| Maryles Joel Michael | 1433 0.152% | $2,020.53 | 2 | 0 | <0.0001% |
Historical Insider Profitability vs. Competitors
$1,138,733 | 28 | -4.94% | $2.79M | |
$63,749,694 | 24 | -12.24% | $2.29M | |
$193,112 | 22 | -20.59% | $1.68M | |
$1,616,354 | 20 | -12.22% | $3.25M | |
$613,181 | 18 | -20.90% | $2.12M |
CMMB Institutional Investors: Active Positions
| Increased Positions | 6 | +25% | 45,850 | +1.01% |
| Decreased Positions | 10 | -41.67% | 434,894 | -9.56% |
| New Positions | 5 | New | 36,144 | New |
| Sold Out Positions | 4 | Sold Out | 65,184 | Sold Out |
| Total Postitions | 20 | -16.67% | 4M | -8.55% |
CMMB Ownership Change vs Market
Institutional Investor Ownership
| Orbimed Advisors Llc | $2,925.00 | 0.61% | 1.74M | 0 | 0% | 2024-12-31 |
| Sphera Funds Management Ltd. | $2,040.00 | 0.42% | 1.21M | 0 | 0% | 2024-12-31 |
| Yelin Lapidot Holdings Management Ltd. | $1,250.00 | 0.26% | 744,127 | -65,590 | -8.1% | 2024-12-31 |
| Ikarian Capital, Llc | $358.00 | 0.07% | 213,052 | -340 | -0.16% | 2024-12-31 |
| Morgan Stanley | $175.00 | 0.04% | 104,400 | -297,872 | -74.05% | 2024-12-31 |
| Kestra Private Wealth Services, Llc | $52.00 | 0.01% | 31,241 | 0 | 0% | 2024-12-31 |
| Boothbay Fund Management, Llc | $44.00 | 0.01% | 26,189 | -340 | -1.28% | 2024-12-31 |
| Xtx Topco Ltd | $42.00 | 0.01% | 24,929 | +9,706 | +63.76% | 2024-12-31 |
| Rhumbline Advisers | $40.00 | 0.01% | 23,808 | -3,765 | -13.65% | 2024-12-31 |
| Virtu Financial Llc | $24.00 | 0.01% | 14,445 | +14,445 | New | 2024-12-31 |